In partnership with
December 16, 2025
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today’s edition tracks a Supreme Court shut door, a DOJ posture that cuts against “normalization,” and a Washington rumor cycle that still needs text before anyone celebrates. We are watching the rescheduling chatter closely, with an eye on what becomes durable and what gets litigated.
Today’s edition is supported by Fisher Investments and Superhuman AI. Interested in becoming a sponsor? Just reach out, we’d love to hear from you!
Finally, we just dropped a new episode of The Hybrid, with special guest Deirdra O’Gorman to discuss the dynamics of cannabis cash management.
⚖️ Federal ceiling holds
🧾 Schedule III watch
🛑 States test the lines
Keep your head. Keep your receipts.
7 Actionable Ways to Achieve a Comfortable Retirement
Your dream retirement isn’t going to fund itself—that’s what your portfolio is for.
When generating income for a comfortable retirement, there are countless options to weigh. Muni bonds, dividends, REITs, Master Limited Partnerships—each comes with risk and oppor-tunity.
The Definitive Guide to Retirement Income from Fisher investments shows you ways you can position your portfolio to help you maintain or improve your lifestyle in retirement.
It also highlights common mistakes, such as tax mistakes, that can make a substantial differ-ence as you plan your well-deserved future.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: The U.S. Supreme Court declined to hear Canna Provisions, Inc., et al. v. Bondi, leaving federal marijuana prohibition intact for now. The petition was the culmination of a deliberate strategy by Massachusetts-based operators and others who raised money, hired elite counsel, and built a test case designed to tee up a modern revisit of Raich. The First Circuit rejected their Commerce Clause and due process theories earlier this year, leaning on existing Supreme Court precedent and treating the policy drift of state legalization as politically interesting and legally irrelevant. The Supreme Court’s denial does not endorse the lower court’s reasoning, and it does not create new precedent. It does keep the federal ceiling exactly where it has been, even as Washington talks about reform in other corners.
💡 Why It Matters: This shuts down the industry’s most ambitious shortcut for now and forces everyone back onto the slower roads. The Court does not want to be the branch that turns state legalization into a national rule, and a conservative majority has every incentive to leave this in the hands of Congress and agencies. Rescheduling efforts can still move the tax and research posture in meaningful ways, yet rescheduling does not rewrite federal supremacy or turn state markets into federally lawful commerce. The Commerce Clause story splits from here. A direct attack on the CSA’s reach needs a new posture that pressures the Court to engage, while the more active legal pressure is already hitting states through dormant Commerce Clause challenges to protectionist licensing schemes. The net effect is practical: constitutional liberation is not a 2026 strategy, and state program design is still getting judged in real time.
🧠 THC Group Take: The industry did everything right on this one. It raised the money, built a clean case, and showed up with serious counsel, and the Court still declined to touch it. That tells you where this sits for a conservative Court: they are not eager to be the branch that turns state legalization into a national rule, and they do not feel boxed in. Rescheduling can still matter a lot, mostly because it brings tax relief and loosens the research bottleneck, yet it does not turn state markets into federally lawful commerce and it does not remove federal discretion from the equation. The Commerce Clause story splits in two from here. A direct constitutional attack on the CSA needs a new posture that leaves the Court fewer ways to sidestep it. The faster-moving fight is the dormant Commerce Clause, where state programs that try to fence out outsiders keep getting dragged into federal court. Everyone wants the clean moment where the cloud lifts and the category becomes normal. That moment has been “next quarter” for a decade at this point. Take any relief you get and turn it into durability, because uncertainty has not left the building.
Fast-moving headlines, flagged for what matters.
The Trump Justice Department told the Supreme Court it should revive the federal gun ban for “unlawful” drug users, arguing marijuana consumers pose a greater danger than alcohol drinkers under the Second Amendment’s history-and-tradition test. The case, U.S. v. Hemani, is the cleanest vehicle Washington has to defend 18 U.S.C. § 922(g)(3), and DOJ is leaning hard on the “dangerousness” frame to justify disarmament. That posture matters beyond the courtroom because it shows how the federal government can talk out of both sides of its mouth in the same month: softer on cannabis scheduling, harder on cannabis users. If rescheduling headlines land, this filing is your reminder that federal relief arrives in slices, not as a cultural pardon. The practical risk stays personal and immediate for patients and consumers who own firearms, and it stays reputational for anyone selling “normalization” as if it is already here. (Marijuana Moment)
President Trump’s expected move to shift marijuana to Schedule III would put real money back into models by easing the 280E burden on ordinary business deductions. It would also change how the federal system behaves day to day, because “accepted medical use” affects research posture, institutional risk tolerance, and how agencies talk about the category in public. The legal posture stays narrow and the constraints stay familiar: no federal legalization, no interstate commerce fix, and no automatic uplisting or banking solution. The article also flags the ripple into hemp politics, where pressure keeps building for national standards that separate age-gated, compliant products from the convenience-store chaos driving enforcement headlines. This is a balance-sheet opportunity paired with an implementation grind, and the grind is where the lawsuits live. (MJBizDaily)
House Oversight Chair James Comer says he supports reclassifying marijuana and grounds it in criminal justice, arguing possession enforcement has driven incarceration that has fallen hardest on minorities. The quote matters because it is plainspoken and politically usable inside the GOP, where plenty of members want to sound reasonable without walking into a legalization fight. This is the lane that can grow votes: proportionality, fairness, and a sense that locking people up over possession now looks ridiculous in half the country. It also draws a quiet line around what this camp will back first, with rescheduling and justice reforms ahead of any national commerce rewrite. If you are counting pathways, this is one of the cleaner ones. (Bloomberg Law)
A Senate Banking subcommittee holds a hearing Tuesday on “Ensuring Fair Access to Banking,” and Tyler Klimas will testify as the Democratic minority’s witness. He ran Nevada’s Cannabis Compliance Board, was there when we launched CANNRA, and now leads Leaf Street Strategies. Even without a cannabis label on the hearing, his presence keeps the industry’s cash and compliance reality in the record where lawmakers can’t dodge it. SAFER is still an uphill battle, with the bill still waiting behind other priorities. Tyler’s a friend and a serious expert, and it is good to see a real regulator’s voice in the witness chair. (Marijuana Moment)
Rand Paul cut the ribbon at Cornbread Hemp’s new Louisville facility and used the moment to take direct aim at last month’s federal hemp language, arguing it would make most CBD and low-THC products illegal when it kicks in next November. He called out the 0.4 mg THC-per-container standard as a practical ban, and he blamed it for overriding state guardrails that already handle age limits and channel control. Paul is pushing for Congress to revise the rule or delay implementation, and he floated a 5 mg per-serving concept as a more realistic federal line while still preferring state control. The subtext is Kentucky politics in a nutshell: McConnell built hemp, then tried to shut the loophole, and Paul is betting the fix overshot the target and is about to hit compliant businesses instead. Farmers do not wait for Washington to finish arguing, so the real clock here is planting season. (Louisville Public Media)
New York’s operators are asking for the same thing every regulated market asks for once the novelty wears off: a rulebook that stays put long enough to follow. The Omnium turbulence and the uneven pace of enforcement have made that harder, and you can feel it in how cautious compliant businesses have become. The Metrc transition support points in the right direction, because pushing inventory entry to January 12th and covering core tag costs reduces the kind of implementation friction that creates bad data and bad blood. Metrc is built for accountability, and New York is making a smart bet by sequencing the rollout in a way that lets licensees get it right the first time. This program has the bones to be a national model, and it will get there faster with a steady leader who can make decisions legible and execution consistent. (GreenState; Harlem World Magazine)
A McPherson retailer and other hemp stakeholders sued after an October KBI raid, arguing Kansas rules for THC-infused products are too unclear to support aggressive enforcement. The KBI and AG Kris Kobach are responding with a hard posture, calling the lawsuit a distraction and pointing to judge-signed warrants as proof they did this by the book. That sets up the real fight: whether Kansas can keep running statewide raids while its definitions, testing protocols, and enforcement standards remain fuzzy enough to invite claims of arbitrary seizures. If the state wants to hammer bad actors, it still has to draw a line that compliant businesses can see before their inventory gets boxed up. Kansas can fix the standard in statute and lab protocols, or it can let a judge write it for them. (Sunflower State Journal; WIBW)
Maine Secretary of State Shenna Bellows approved a citizen initiative for signature gathering that would unwind the state’s adult-use cannabis program and end home cultivation for adults. The campaign now needs 67,682 valid signatures by Feb. 2, 2026 to land on the 2026 general election ballot, with a later path for 2027 if it misses that window. The stakes are real: the proposal would target a roughly $250 million annual market, thousands of jobs, and a revenue stream built since adult-use sales began in October 2020. It also puts the spotlight back on Maine’s tax structure, including the 10% excise and the $335-per-pound cultivation tax that already weighs on compliant operators. This is a reminder that legalization still lives on political consent, and consent gets tested when organized opponents decide they want their old map back. (Cannabis Business Times)
Michigan’s adult-use flower prices have slipped below $60 an ounce on average as outdoor-grown supply hits the system and deepens an already crowded market. Growers and processors feel it first, because wholesale compression shows up before retail can fully reprice, and the stress forces layoffs, distressed sales, or quiet exits. Retailers can move volume on bargain pricing, yet the long-term risk is a market that trains consumers to expect permanent discounts and punishes anyone carrying higher-cost inventory. The harvest surge also brings familiar temptations, from corner-cutting to the kind of “mystery product” that keeps labs and regulators busy. Michigan keeps proving a blunt truth: when supply arrives all at once, even a strong retail footprint can turn into a race to the bottom. (Crain’s Detroit Business)
Washington Beer Blog frames cannabis beverages as a category quietly taking the same “after work, hang out, unwind” occasions craft beer used to own, right as breweries grind through lower volume and shakier orders. The advantage the piece keeps coming back to is channel, with hemp-derived drinks riding ordinary retail pathways in many states while cannabis dispensary rules stay fragmented. It also notes big beverage interest, which usually means consumer data has gotten loud enough to push past stigma and legal risk. The article gets a little too tidy about dosing and predictability, since real-world experiences vary widely by product, formulation, and state rules. Still, the strategic point is hard to ignore: if your business sells occasions, you should pay attention when a new product starts owning them. (Washington Beer Blog)
President Trump told reporters Monday he is “very strongly” considering rescheduling marijuana, framing the move as a way to boost research. The comment matters because it turns the week’s chatter into an on-the-record statement from the only person who can set the administration’s direction. The article also notes the gap between direction and durability, since rescheduling still lives inside DOJ process and the paperwork is where delays and lawsuits show up. The practical posture is readiness, not celebration: model the 280E upside, keep expectations disciplined, and watch for the actual procedural move that makes this real. Washington just raised the volume. The industry still has to read the fine print. (Marijuana Moment)
A new Marijuana Moment and NuggMD tracking poll finds just 6% of frequent cannabis consumers in legal states approve of the Trump administration’s cannabis actions so far, with a big neutral bloc and a larger disapproving bloc doing the talking. The same respondents are also telling the White House exactly where the leverage is: 51% say they’d be more likely to support the administration if it reschedules or legalizes marijuana. The detail that matters is timing, because the survey was conducted before the latest round of “imminent” reporting, so this is the baseline before any real action or official text hits. Politically, it reads like a wide-open lane paired with a trust gap: the audience is persuadable, and they’re also tired of promises. If the administration wants the credit, it has to deliver something people can point to without squinting. (Marijuana Moment)
The Gold standard for AI news
AI will eliminate 300 million jobs in the next 5 years.
Yours doesn't have to be one of them.
Here's how to future-proof your career:
Join the Superhuman AI newsletter - read by 1M+ professionals
Learn AI skills in 3 mins a day
Become the AI expert on your team
From the hearing room to the comment section — we’re watching it all.
📄 CANNRA’s new Schedule 3 briefing reads like what it is: state regulators trying to separate the real changes from the internet fog. The big takeaway is practical, with 280E relief and research access as the near-term shifts, paired with a reminder that state markets still live in federal tension until agencies and Congress do more than change a schedule number. (CANNRA)
🧬 A lab study found CBD and THC, especially together, inhibited ovarian cancer cell growth and invasion in preclinical experiments, including a platinum-resistant cell line. It is a research signal, not a clinical claim, and it mostly reinforces how much medical promise is still stuck behind slow pathways to real-world trials. (Marijuana Moment)
🍸 A StupidDOPE essay leans on the real global math that alcohol kills at scale, then tries to win the argument by calling cannabis “zero deaths.” The double standard point lands harder when you drop the absolutism and make the case like a grown-up: regulate marketing, age-gate hard, enforce impaired driving, and stop pretending the two categories carry the same public-health burden. (StupidDOPE)
🗳️ Ultra Health CEO Duke Rodriguez, a Republican and former Gary Johnson cabinet secretary, just entered New Mexico’s crowded 2026 governor’s race. A major operator stepping onto the ballot forces the state to talk about cannabis as governance, not a culture-war prop. (New Mexico Political Report)